Invention Grant
- Patent Title: Integrin antagonists
-
Application No.: US16544259Application Date: 2019-08-19
-
Publication No.: US10703752B2Publication Date: 2020-07-07
- Inventor: Ove Pedersen , Elke Vermassen
- Applicant: OXURION NV
- Applicant Address: BE Leuven
- Assignee: OXURION NV
- Current Assignee: OXURION NV
- Current Assignee Address: BE Leuven
- Agency: Christensen O'Connor Johnson Kindness PLLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@33299101 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@33dbef26
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K9/00
Abstract:
The present invention relates to novel integrin antagonists of Formula I and their use as a medicament, in particular for inhibiting neovascularization.
Public/Granted literature
- US20200055849A1 INTEGRIN ANTAGONISTS Public/Granted day:2020-02-20
Information query
